Wednesday, January 27, 2021

USFDA grants orphan drug designation to Zydus Cadila#39;s Saroglitazar Mg

USFDA grants orphan drug designation to Zydus Cadila#39;s Saroglitazar Mg Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity upon USFDA approval.

from Moneycontrol Business News https://ift.tt/3a9IPWL
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...